Hyundai Pharmaceutical Co., Ltd. (004310.KS) KSC

7,520.00

+760(+11.24%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap91.46B
Enterprise Value129.26B
P/E Ratio-97.46
PEG Ratio16.76
Price/Sales Ratio1.09
Price/Book Ratio2.49
Enterprise/Revenue1.33
Enterprise/EBITDA139.76

Fiscal Year

Fiscal YearNovember 30, 2024
Most Recent QuarterAugust 31, 2025

Profitability

Profit Margin-0.01
Operating Margin-0.01

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.03

Income Statement

Revenue175.74B
Revenue/Share6,985.77
Gross Profit73.37B
EBITDA3.94B
Net Income-574.89M
Diluted EPS-22.41

Balance Sheet

Total Cash2.35B
Total Cash/Share190.9
Total Debt47.74B
Total Debt/Equity0.61
Current Ratio1.11
Book Value Per Share3,017.1

Price History

52-Week Change107.16
52-Week High8,780
52-Week Low2,995
Moving Average 50 Days4,463.7
Moving Average 200 Days3,823.58

Statistics

Average Volume2.33M
Shares Outstanding26.14M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate30
Trailing Annual Dividend Yield0.4
Payout Ratio0
Last Split Factor513:500
Last Split DateOctober 20, 2017